DNMT3A and thymoma: From the DNA promoter methylation analyses performed in this study, the involvement of MTHFR and DNMT3A methylation in thymoma-associated myasthenia gravis has been proven, even if other studies are needed to assess a potential pathogenic role of these genes in TAMG.